失代偿性肝硬化和大容量穿刺对生存的影响:一项回顾性队列研究

IF 3.7 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Karla P. Perez-Lopez, Miriam G. Reyes-Zermeño
{"title":"失代偿性肝硬化和大容量穿刺对生存的影响:一项回顾性队列研究","authors":"Karla P. Perez-Lopez,&nbsp;Miriam G. Reyes-Zermeño","doi":"10.1016/j.aohep.2025.101804","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction and Objectives</h3><div>Ascites is the most common complication of cirrhosis. Its presence represents a 40% mortality at 2 years. The objective of this study was to determine survival in patients with decompensated liver cirrhosis due to ascites undergoing large-volume paracentesis.</div></div><div><h3>Materials and Patients</h3><div>A retrospective, cross-sectional, observational, analytical study was conducted. Patients with liver cirrhosis over 18 years of age of both sexes, of any etiology, treated at Centro Médico Nacional 20 de Noviembre between January 2013 and June 2023, who underwent large volume paracentesis, were selected and matched 2:1 with controls who did not require high volume paracentesis, adjusted for disease severity, age, sex, and Child-Pugh stage. Exclusion criteria were pregnancy or lactation, under 18 years of age, and ascites of a different origin than chronic liver disease. The data was extracted from clinical records.</div></div><div><h3>Results</h3><div>A total of 226 patients were analyzed, 61.9% women (n=140) and 38.1% men (n=86). The average age was 64.28 years (SD=13.33). The minimum age was 19 years and maximum was 91 years. The most frequent etiology was hepatic steatosis in 34.07% (n=77), followed by hepatitis C in 19.91% (n=45), alcoholism in 12.38% (n=28), autoimmune hepatitis in 10.17% (n=23). The distribution of patients by Child-Pugh classification was B in 69% (n=156) and C in 31% (n=70). The average MELD-NA score was 16.93 (SD=7.10). The main comorbidities were 36.7% (n=83) type 2 diabetes mellitus, 24.8% (n=56) systemic arterial hypertension, 15% (n=34) chronic kidney disease, and 16.4% (n=37) obesity.</div><div>Out the 226 patients with liver cirrhosis with ascites, 33.2% (n=75) underwent large volume paracentesis while 66.8% (n=151) underwent paracentesis less than 5 liters. The mortality of patients undergoing large volume paracentesis was 32% compared to 20.5% RR 1.55, IC 95% (0.98-2.45) of patients who did not. In bivariate analysis by sex, there were no statistically significant differences in mortality. Stratified analysis by nutritional status with body mass index did not show differences in mortality in patients undergoing large volume paracentesis.</div></div><div><h3>Conclusions</h3><div>No statistically significant differences in mortality were observed between patients undergoing large volume paracentesis and those who did not. It is important to consider that factors other than paracentesis volume may influence patient survival.</div></div>","PeriodicalId":7979,"journal":{"name":"Annals of hepatology","volume":"30 ","pages":"Article 101804"},"PeriodicalIF":3.7000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Impact on survival of decompensated liver cirrhosis and large volume paracentesis: a retrospective cohort\",\"authors\":\"Karla P. Perez-Lopez,&nbsp;Miriam G. Reyes-Zermeño\",\"doi\":\"10.1016/j.aohep.2025.101804\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction and Objectives</h3><div>Ascites is the most common complication of cirrhosis. Its presence represents a 40% mortality at 2 years. The objective of this study was to determine survival in patients with decompensated liver cirrhosis due to ascites undergoing large-volume paracentesis.</div></div><div><h3>Materials and Patients</h3><div>A retrospective, cross-sectional, observational, analytical study was conducted. Patients with liver cirrhosis over 18 years of age of both sexes, of any etiology, treated at Centro Médico Nacional 20 de Noviembre between January 2013 and June 2023, who underwent large volume paracentesis, were selected and matched 2:1 with controls who did not require high volume paracentesis, adjusted for disease severity, age, sex, and Child-Pugh stage. Exclusion criteria were pregnancy or lactation, under 18 years of age, and ascites of a different origin than chronic liver disease. The data was extracted from clinical records.</div></div><div><h3>Results</h3><div>A total of 226 patients were analyzed, 61.9% women (n=140) and 38.1% men (n=86). The average age was 64.28 years (SD=13.33). The minimum age was 19 years and maximum was 91 years. The most frequent etiology was hepatic steatosis in 34.07% (n=77), followed by hepatitis C in 19.91% (n=45), alcoholism in 12.38% (n=28), autoimmune hepatitis in 10.17% (n=23). The distribution of patients by Child-Pugh classification was B in 69% (n=156) and C in 31% (n=70). The average MELD-NA score was 16.93 (SD=7.10). The main comorbidities were 36.7% (n=83) type 2 diabetes mellitus, 24.8% (n=56) systemic arterial hypertension, 15% (n=34) chronic kidney disease, and 16.4% (n=37) obesity.</div><div>Out the 226 patients with liver cirrhosis with ascites, 33.2% (n=75) underwent large volume paracentesis while 66.8% (n=151) underwent paracentesis less than 5 liters. The mortality of patients undergoing large volume paracentesis was 32% compared to 20.5% RR 1.55, IC 95% (0.98-2.45) of patients who did not. In bivariate analysis by sex, there were no statistically significant differences in mortality. Stratified analysis by nutritional status with body mass index did not show differences in mortality in patients undergoing large volume paracentesis.</div></div><div><h3>Conclusions</h3><div>No statistically significant differences in mortality were observed between patients undergoing large volume paracentesis and those who did not. It is important to consider that factors other than paracentesis volume may influence patient survival.</div></div>\",\"PeriodicalId\":7979,\"journal\":{\"name\":\"Annals of hepatology\",\"volume\":\"30 \",\"pages\":\"Article 101804\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of hepatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1665268125000286\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of hepatology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1665268125000286","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

腹水是肝硬化最常见的并发症。它的存在导致2岁时40%的死亡率。本研究的目的是确定因腹水而失代偿性肝硬化患者接受大容量穿刺的生存率。材料与患者回顾性、横断面、观察性、分析性研究。选择2013年1月至2023年6月期间在国家msamicdico中心接受大容量穿刺治疗的18岁以上肝硬化患者,不论病因,不论男女,与不需要大容量穿刺的对照组进行2:1匹配,并根据疾病严重程度、年龄、性别和儿童- pugh分期进行调整。排除标准为妊娠或哺乳期,年龄在18岁以下,以及与慢性肝病病因不同的腹水。数据从临床记录中提取。结果共分析226例患者,其中女性140例(61.9%),男性86例(38.1%)。平均年龄64.28岁(SD=13.33)。最低年龄为19岁,最高年龄为91岁。最常见的病因是肝脂肪变性(34.07%,n=77),其次是丙型肝炎(19.91%,n=45),酒精中毒(12.38%,n=28),自身免疫性肝炎(10.17%,n=23)。Child-Pugh分型患者分布为69% (n=156)为B型,31% (n=70)为C型。MELD-NA平均评分为16.93分(SD=7.10)。主要合并症为36.7% (n=83) 2型糖尿病,24.8% (n=56)全身性动脉高血压,15% (n=34)慢性肾脏疾病,16.4% (n=37)肥胖。226例肝硬化合并腹水患者中,33.2% (n=75)行大容量放空,66.8% (n=151)行小于5升放空。接受大容量穿刺的患者死亡率为32%,未接受大容量穿刺的患者死亡率为20.5%,RR为1.55,IC为95%(0.98-2.45)。在按性别进行的双变量分析中,死亡率没有统计学上的显著差异。营养状况与体重指数的分层分析没有显示大容量穿刺患者死亡率的差异。结论大容量穿刺患者与未行大容量穿刺患者的死亡率无统计学差异。重要的是要考虑除穿刺量以外的其他因素可能影响患者的生存。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Impact on survival of decompensated liver cirrhosis and large volume paracentesis: a retrospective cohort

Introduction and Objectives

Ascites is the most common complication of cirrhosis. Its presence represents a 40% mortality at 2 years. The objective of this study was to determine survival in patients with decompensated liver cirrhosis due to ascites undergoing large-volume paracentesis.

Materials and Patients

A retrospective, cross-sectional, observational, analytical study was conducted. Patients with liver cirrhosis over 18 years of age of both sexes, of any etiology, treated at Centro Médico Nacional 20 de Noviembre between January 2013 and June 2023, who underwent large volume paracentesis, were selected and matched 2:1 with controls who did not require high volume paracentesis, adjusted for disease severity, age, sex, and Child-Pugh stage. Exclusion criteria were pregnancy or lactation, under 18 years of age, and ascites of a different origin than chronic liver disease. The data was extracted from clinical records.

Results

A total of 226 patients were analyzed, 61.9% women (n=140) and 38.1% men (n=86). The average age was 64.28 years (SD=13.33). The minimum age was 19 years and maximum was 91 years. The most frequent etiology was hepatic steatosis in 34.07% (n=77), followed by hepatitis C in 19.91% (n=45), alcoholism in 12.38% (n=28), autoimmune hepatitis in 10.17% (n=23). The distribution of patients by Child-Pugh classification was B in 69% (n=156) and C in 31% (n=70). The average MELD-NA score was 16.93 (SD=7.10). The main comorbidities were 36.7% (n=83) type 2 diabetes mellitus, 24.8% (n=56) systemic arterial hypertension, 15% (n=34) chronic kidney disease, and 16.4% (n=37) obesity.
Out the 226 patients with liver cirrhosis with ascites, 33.2% (n=75) underwent large volume paracentesis while 66.8% (n=151) underwent paracentesis less than 5 liters. The mortality of patients undergoing large volume paracentesis was 32% compared to 20.5% RR 1.55, IC 95% (0.98-2.45) of patients who did not. In bivariate analysis by sex, there were no statistically significant differences in mortality. Stratified analysis by nutritional status with body mass index did not show differences in mortality in patients undergoing large volume paracentesis.

Conclusions

No statistically significant differences in mortality were observed between patients undergoing large volume paracentesis and those who did not. It is important to consider that factors other than paracentesis volume may influence patient survival.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Annals of hepatology
Annals of hepatology 医学-胃肠肝病学
CiteScore
7.90
自引率
2.60%
发文量
183
审稿时长
4-8 weeks
期刊介绍: Annals of Hepatology publishes original research on the biology and diseases of the liver in both humans and experimental models. Contributions may be submitted as regular articles. The journal also publishes concise reviews of both basic and clinical topics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信